Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult and pediatric patients.
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...
ICON, which builds homes using 3D printing, has closed on $56 million in Series C funding co-led by Norwest Venture Partners ...
Muhdo Group is proud to announce the addition of Randy Oostra, CEO of BlueprintN1 and former President and CEO of ProMedica, ...
BMG announced the launch of a new brand identity that the company hopes will align with its strategic vision and direction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback